| Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, SW Behrman, AB Benson, ... Journal of the National Comprehensive Cancer Network 19 (4), 439-457, 2021 | 966 | 2021 |
| NCCN guidelines insights: pancreatic adenocarcinoma, version 1.2019: featured updates to the NCCN guidelines MA Tempero, MP Malafa, EG Chiorean, B Czito, C Scaife, AK Narang, ... Journal of the National Comprehensive Cancer Network 17 (3), 202-210, 2019 | 403 | 2019 |
| Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection G Gemenetzis, VP Groot, AB Blair, DA Laheru, L Zheng, AK Narang, ... Annals of surgery 270 (2), 340-347, 2019 | 394 | 2019 |
| Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy JD Gottsch, OH Sundin, SH Liu, AS Jun, KW Broman, WJ Stark, ECL Vito, ... Investigative ophthalmology & visual science 46 (6), 1934-1939, 2005 | 249 | 2005 |
| Out-of-pocket spending and financial burden among Medicare beneficiaries with cancer AK Narang, LH Nicholas JAMA oncology 3 (6), 757-765, 2017 | 237 | 2017 |
| The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma AT Wild, X Ye, SG Ellsworth, JA Smith, AK Narang, T Garg, J Campian, ... American journal of clinical oncology 38 (3), 259-265, 2015 | 208 | 2015 |
| Circulating tumor DNA as a clinical test in resected pancreatic cancer VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ... Clinical Cancer Research 25 (16), 4973-4984, 2019 | 168 | 2019 |
| Trends in advance care planning in patients with cancer: results from a national longitudinal survey AK Narang, AA Wright, LH Nicholas JAMA oncology 1 (5), 601-608, 2015 | 143 | 2015 |
| Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study AK Narang, RC Miller, CC Hsu, S Bhatia, TM Pawlik, D Laheru, ... Radiation oncology 6, 1-11, 2011 | 119 | 2011 |
| Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas, T Xia, G Mo, ... Cancer Cell 40 (11), 1374-1391. e7, 2022 | 93 | 2022 |
| The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer JM Herman, AK Narang, KA Griffith, MM Zalupski, JB Reese, SL Gearhart, ... International Journal of Radiation Oncology* Biology* Physics 85 (1), e15-e19, 2013 | 77 | 2013 |
| Outcome of patients with borderline resectable pancreatic cancer in the contemporary era of neoadjuvant chemotherapy AA Javed, MJ Wright, A Siddique, AB Blair, D Ding, RA Burkhart, ... Journal of Gastrointestinal Surgery 23, 112-121, 2019 | 75 | 2019 |
| Socioeconomic factors affect the selection of proton radiation therapy for children CJ Shen, C Hu, MM Ladra, AK Narang, CE Pollack, SA Terezakis Cancer 123 (20), 4048-4056, 2017 | 66 | 2017 |
| Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer CC Hsu, CL Wolfgang, DA Laheru, TM Pawlik, MJ Swartz, JM Winter, ... Journal of Gastrointestinal Surgery 16 (4), 753-761, 2012 | 62 | 2012 |
| A novel absorbable radiopaque hydrogel spacer to separate the head of the pancreas and duodenum in radiation therapy for pancreatic cancer AD Rao, Z Feng, EJ Shin, J He, KM Waters, S Coquia, R DeJong, ... International Journal of Radiation Oncology* Biology* Physics 99 (5), 1111-1120, 2017 | 58 | 2017 |
| CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma J Wang, MT Saung, K Li, J Fu, K Fujiwara, N Niu, S Muth, J Wang, Y Xu, ... Journal of Experimental Medicine 219 (5), e20211631, 2022 | 45 | 2022 |
| Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma: a multi-institutional experience J Wang, AK Narang, EA Sugar, B Luber, LM Rosati, CC Hsu, CD Fuller, ... Annals of surgical oncology 22, 1100-1106, 2015 | 43 | 2015 |
| Molecularly targeted agents as radiosensitizers in cancer therapy—focus on prostate cancer S Alcorn, AJ Walker, N Gandhi, A Narang, AT Wild, RK Hales, JM Herman, ... International journal of molecular sciences 14 (7), 14800-14832, 2013 | 43 | 2013 |
| Stereotactic body radiation therapy for isolated local recurrence after surgical resection of pancreatic ductal adenocarcinoma appears to be safe and effective JF Ryan, VP Groot, LM Rosati, A Hacker-Prietz, AK Narang, TR McNutt, ... Annals of surgical oncology 25, 280-289, 2018 | 42 | 2018 |
| A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable … T Heumann, C Judkins, K Li, SJ Lim, J Hoare, R Parkinson, H Cao, ... Nature communications 14 (1), 3650, 2023 | 39 | 2023 |
